CLINICAL PHASE DEVELOPMENT LTD
Company number 07715640 · Active · Redhill RH1 6BF
CLINICAL PHASE DEVELOPMENT LTD is an active private limited company (company number 07715640) incorporated on 22 July 2011, registered in Redhill. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 July 2025, showing net assets of £112k, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 5% on the prior period (£106k).
By net assets it sits in the upper half of 54 comparable companies in Surrey (median £1,000, upper quartile £121k).
Key dates
- Incorporated
- 22 July 2011
- Next accounts due
- 30 April 2027 — in 192 days
- Confirmation statement due
- 5 August 2027 — in 289 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- Micro (Companies Act thresholds)
Financials — 2 periods on record, latest ending 31 July 2025
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 July 2025 | £112k | — | — | £25k | — | — | 0 |
| 31 July 2024 | £106k | — | — | £29k | — | — | 0 |
- Current ratio
- 5.17 — comfortable
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Firmoscan score: 76/100 (grade B)
- +10 Positive net assets — Net assets £111,700 at 2025-07-31
- +8 Comfortable liquidity — Current ratio 5.17
- +8 Established — Incorporated 2011-07-22 (15 years)
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice.
Ownership and control
- Mr Sean Edgar Bennett — owns 75–100% of shares · since 22 July 2016
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Similar companies in Surrey
Same activity (research and experimental development on biotechnology), closest in incorporation date.
- LGC GENOMICS LIMITED — Guildford, inc. Jun 2011
- CLINICOLOGY LTD. — Guildford, inc. Oct 2011
- METAMO PROCESS TECHNOLOGY LTD. — Bordon, inc. Jan 2011
- MUCOSAL DIAGNOSTICS LIMITED — Midhurst, inc. Mar 2012
- THE NATIVE ANTIGEN COMPANY LIMITED — Guildford, inc. Sept 2010
- OUTLOOK THERAPEUTICS LTD — Guildford, inc. Aug 2012
Reminders for CLINICAL PHASE DEVELOPMENT LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.